Phenylacetic Acid and Arterial Vascular Properties in Patients with Chronic Kidney Disease Stage 5 on Hemodialysis Therapy

Publisher： Karger

E-ISSN： 1660-2110|107|1|c1-c6

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.107, Iss.1, 2007-07, pp. : c1-c6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Acetylcysteine Improves Arterial Vascular Reactivity in Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 112, Iss. 3, 2009-05 ,pp. : c184-c189

Karger

Access to resources Recommend Favorite

Markers of Arterial Stiffness Are Risk Factors for Progression to End-Stage Renal Disease among Patients with Chronic Kidney Disease Stages 4 and 5

By  

Nephron Clin Pract, Vol. 107, Iss. 4, 2007-11 ,pp. : c177-c181

Karger

Access to resources Recommend Favorite

Multidisciplinary Care Improves Outcome of Patients with Stage 5 Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 115, Iss. 4, 2010-04 ,pp. : c283-c288

Karger

Access to resources Recommend Favorite

The Risk of Gallbladder Stone Formation Is Increased in Patients with Predialysis Chronic Kidney Disease but Not Those Undergoing Chronic Hemodialysis Therapy

By  

Nephron Clin Pract, Vol. 111, Iss. 3, 2009-02 ,pp. : c167-c172

Karger

Access to resources Recommend Favorite

Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 6, 2015-11 ,pp. : 587-593

John Wiley & Sons Inc

Access to resources Recommend Favorite